retatrutide dosage retatrutide clinical trial dosage Understanding the starting dose A Clinician's Guide to Retatrutide

The choice of initial pharmacotherapy has emerged as an area of uncertainty in patients with newly diagnosed T2D who have or are at risk of ASCVD

GIP enhances insulin secretion, but it also appears to work on fat cells directly, improving how your body handles dietary fat

Why Triple Agonism May Offer Unique Benefits Retatrutide distinguishes itself from other GLP-1 medications through its triple-agonist mechanism, simultaneously activating GLP-1, GIP, and glucagon receptors

What happens if retatrutide doesn't get approved

Some skin will remain loose, even with treatment

The first draft of this transcript was created by Descript, an AI transcription tool